Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Vella

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Journal of Chemotherapy (Florence, Italy)|February 12, 2019
Short-term adverse effects of anticancer drugs in patients with type 2 diabetesAgostino Milluzzo, Andrea Tumminia, Veronica Vella, et al.
Biomedicines|January 21, 2023
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance?Antonino Belfiore, Rosaria Valentina Rapicavoli, Rosario Le Moli, et al.
The Journal of Clinical Endocrinology and Metabolism|July 8, 2015
Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic FeaturesFiorenza Gianì, Veronica Vella, Maria Luisa Nicolosi, et al.
Endocrine-Related Cancer|December 3, 2005
The p53-homologue p63 may promote thyroid cancer progressionRoberta Malaguarnera, Angelo Mandarino, Emanuela Mazzon, et al.
The Journal of Clinical Endocrinology and Metabolism|April 6, 2013
Thyroid cancer cell resistance to gefitinib depends on the constitutive oncogenic activation of the ERK pathwayFrancesco Frasca, Veronica Vella, Maria Luisa Nicolosi, et al.
Molecular and Cellular Endocrinology|August 8, 2022
Comparative proteomic analysis of insulin receptor isoform A and B signalingRoberta Malaguarnera, Caterina Gabriele, Gianluca Santamaria, et al.
International Journal of Surgical Oncology|November 19, 2019
Thyroidectomy as Treatment of Choice for Differentiated Thyroid CancerDario Giuffrida, Raffaella Giuffrida, Ivana Puliafito, et al.
International Journal of Cancer|June 8, 2011
Reactivation of p53 mutants by prima-1 [corrected] in thyroid cancer cellsRosa Linda Messina, Mariangela Sanfilippo, Veronica Vella, et al.
Endocrine Research|October 17, 2024
Sporadic and Familial Medullary Thyroid Carcinoma: A Retrospective Single Center Study on Presentation and OutcomeAntonio Prinzi, Veronica Vella, Agata Bosco, et al.
Oncotarget|June 8, 2017
Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cellsVeronica Vella, Roberta Malaguarnera, Maria Luisa Nicolosi, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Chemotherapy (Florence, Italy)|February 12, 2019
Short-term adverse effects of anticancer drugs in patients with type 2 diabetesAgostino Milluzzo, Andrea Tumminia, Veronica Vella, et al.
Biomedicines|January 21, 2023
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance?Antonino Belfiore, Rosaria Valentina Rapicavoli, Rosario Le Moli, et al.
The Journal of Clinical Endocrinology and Metabolism|July 8, 2015
Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic FeaturesFiorenza Gianì, Veronica Vella, Maria Luisa Nicolosi, et al.
Endocrine-Related Cancer|December 3, 2005
The p53-homologue p63 may promote thyroid cancer progressionRoberta Malaguarnera, Angelo Mandarino, Emanuela Mazzon, et al.
The Journal of Clinical Endocrinology and Metabolism|April 6, 2013
Thyroid cancer cell resistance to gefitinib depends on the constitutive oncogenic activation of the ERK pathwayFrancesco Frasca, Veronica Vella, Maria Luisa Nicolosi, et al.
Molecular and Cellular Endocrinology|August 8, 2022
Comparative proteomic analysis of insulin receptor isoform A and B signalingRoberta Malaguarnera, Caterina Gabriele, Gianluca Santamaria, et al.
International Journal of Surgical Oncology|November 19, 2019
Thyroidectomy as Treatment of Choice for Differentiated Thyroid CancerDario Giuffrida, Raffaella Giuffrida, Ivana Puliafito, et al.
International Journal of Cancer|June 8, 2011
Reactivation of p53 mutants by prima-1 [corrected] in thyroid cancer cellsRosa Linda Messina, Mariangela Sanfilippo, Veronica Vella, et al.
Endocrine Research|October 17, 2024
Sporadic and Familial Medullary Thyroid Carcinoma: A Retrospective Single Center Study on Presentation and OutcomeAntonio Prinzi, Veronica Vella, Agata Bosco, et al.
Oncotarget|June 8, 2017
Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cellsVeronica Vella, Roberta Malaguarnera, Maria Luisa Nicolosi, et al.
Pageof 6